These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16892345)

  • 61. Synthesis, characterization, and metabolism studies of fluspidine enantiomers.
    Holl K; Falck E; Köhler J; Schepmann D; Humpf HU; Brust P; Wünsch B
    ChemMedChem; 2013 Dec; 8(12):2047-56. PubMed ID: 24130175
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Electron density guided fragment-based lead discovery of ketohexokinase inhibitors.
    Gibbs AC; Abad MC; Zhang X; Tounge BA; Lewandowski FA; Struble GT; Sun W; Sui Z; Kuo LC
    J Med Chem; 2010 Nov; 53(22):7979-91. PubMed ID: 21033679
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Relationships between the structure of 6-allyl-6,8-diazabicyclo[3.2.2]nonane derivatives and their sigma receptor affinity and cytotoxic activity.
    Holl R; Schepmann D; Grünert R; Bednarski PJ; Wünsch B
    Bioorg Med Chem; 2009 Jan; 17(2):777-93. PubMed ID: 19081725
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structure of the σ1 receptor and its ligand binding site.
    Brune S; Pricl S; Wünsch B
    J Med Chem; 2013 Dec; 56(24):9809-19. PubMed ID: 23964901
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds.
    Cappelli A; Pericot Mohr Gl; Giuliani G; Galeazzi S; Anzini M; Mennuni L; Ferrari F; Makovec F; Kleinrath EM; Langer T; Valoti M; Giorgi G; Vomero S
    J Med Chem; 2006 Nov; 49(22):6451-64. PubMed ID: 17064065
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sigma receptor ligands: applications in inflammation and oncology.
    Bourrie B; Bribes E; Derocq JM; Vidal H; Casellas P
    Curr Opin Investig Drugs; 2004 Nov; 5(11):1158-63. PubMed ID: 15573866
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives.
    Zampieri D; Mamolo MG; Laurini E; Florio C; Zanette C; Fermeglia M; Posocco P; Paneni MS; Pricl S; Vio L
    J Med Chem; 2009 Sep; 52(17):5380-93. PubMed ID: 19673530
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis of novel sigma-receptor ligands from methyl alpha-D-mannopyranoside.
    Wiedemeyer K; Wünsch B
    Carbohydr Res; 2006 Oct; 341(14):2321-34. PubMed ID: 16854396
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dancing of the second aromatic residue around the 6,8-diazabicyclo[3.2.2]nonane framework: influence on sigma receptor affinity and cytotoxicity.
    Holl R; Schepmann D; Fröhlich R; Grünert R; Bednarski PJ; Wünsch B
    J Med Chem; 2009 Apr; 52(7):2126-37. PubMed ID: 19243173
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation.
    Akutsu T; Kobayashi K; Sakurada K; Ikegaya H; Furihata T; Chiba K
    Drug Metab Dispos; 2007 Jan; 35(1):72-8. PubMed ID: 17020955
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists.
    Chen C; Tucci FC; Jiang W; Tran JA; Fleck BA; Hoare SR; Wen J; Chen T; Johns M; Markison S; Foster AC; Marinkovic D; Chen CW; Arellano M; Harman J; Saunders J; Bozigian H; Marks D
    Bioorg Med Chem; 2008 May; 16(10):5606-18. PubMed ID: 18417348
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design and evaluation of naphthol- and carbazole-containing fluorescent sigma ligands as potential probes for receptor binding studies.
    Ferorelli S; Abate C; Colabufo NA; Niso M; Inglese C; Berardi F; Perrone R
    J Med Chem; 2007 Sep; 50(19):4648-55. PubMed ID: 17713896
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potent and orally active ET(A) selective antagonists with 5,7-diarylcyclopenteno[1,2-b]pyridine-6-carboxylic acid structures.
    Yoshizumi T; Takahashi H; Ohtake N; Jona H; Sato Y; Kishino H; Sakamoto T; Ozaki S; Takahashi H; Shibata Y; Ishii Y; Saito M; Okada M; Hayama T; Nishikibe M
    Bioorg Med Chem; 2004 May; 12(9):2139-50. PubMed ID: 15080914
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis, pharmacological evaluation, and σ1 receptor interaction analysis of hydroxyethyl substituted piperazines.
    Weber F; Brune S; Korpis K; Bednarski PJ; Laurini E; Dal Col V; Pricl S; Schepmann D; Wünsch B
    J Med Chem; 2014 Apr; 57(7):2884-94. PubMed ID: 24617836
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of hyperpolarization-activated cation currents by phencyclidine and some sigma ligands in rat hippocampal CA1 pyramidal neurons in vitro.
    Tanabe M
    Neuropharmacology; 2007 Sep; 53(3):406-14. PubMed ID: 17631922
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
    Arena E; Cacciatore I; Cerasa LS; Turkez H; Pittalà V; Pasquinucci L; Marrazzo A; Parenti C; Di Stefano A; Prezzavento O
    Bioorg Med Chem; 2016 Jul; 24(14):3149-56. PubMed ID: 27262426
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel 4-(4-aryl)cyclohexyl-1-(2-pyridyl)piperazines as Delta(8)-Delta(7) sterol isomerase (emopamil binding protein) selective ligands with antiproliferative activity.
    Berardi F; Abate C; Ferorelli S; de Robertis AF; Leopoldo M; Colabufo NA; Niso M; Perrone R
    J Med Chem; 2008 Dec; 51(23):7523-31. PubMed ID: 19053780
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The sigma enigma: in vitro/in silico site-directed mutagenesis studies unveil σ1 receptor ligand binding.
    Brune S; Schepmann D; Klempnauer KH; Marson D; Dal Col V; Laurini E; Fermeglia M; Wünsch B; Pricl S
    Biochemistry; 2014 May; 53(18):2993-3003. PubMed ID: 24766040
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.
    Siracusa MA; Salerno L; Modica MN; Pittalà V; Romeo G; Amato ME; Nowak M; Bojarski AJ; Mereghetti I; Cagnotto A; Mennini T
    J Med Chem; 2008 Aug; 51(15):4529-38. PubMed ID: 18598015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.